Agilent Applied sciences A is getting ready to launch its quarterly earnings on Monday, 2024-11-25. This is a quick overview of what buyers ought to take into accout earlier than the announcement.
Analysts anticipate Agilent Applied sciences to report an earnings per share (EPS) of $1.40.
Buyers in Agilent Applied sciences are eagerly awaiting the corporate’s announcement, hoping for information of surpassing estimates and constructive steerage for the following quarter.
It is value noting for brand new buyers that inventory costs might be closely influenced by future projections relatively than simply previous efficiency.
Earnings Monitor File
Final quarter the corporate beat EPS by $0.06, which was adopted by a 0.16% enhance within the share value the following day.
This is a have a look at Agilent Applied sciences’s previous efficiency and the ensuing value change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | This autumn 2023 |
---|---|---|---|---|
EPS Estimate | 1.26 | 1.19 | 1.22 | 1.35 |
EPS Precise | 1.32 | 1.22 | 1.29 | 1.38 |
Worth Change % | 0.0% | -10.0% | 3.0% | 9.0% |
Market Efficiency of Agilent Applied sciences’s Inventory
Shares of Agilent Applied sciences have been buying and selling at $132.06 as of November 21. Over the past 52-week interval, shares are up 5.86%. Provided that these returns are usually constructive, long-term shareholders needs to be happy going into this earnings launch.
Analyst Observations about Agilent Applied sciences
Understanding market sentiments and expectations inside the business is essential for buyers. This evaluation delves into the newest insights on Agilent Applied sciences.
Analysts have supplied Agilent Applied sciences with 3 rankings, leading to a consensus score of Impartial. The common one-year value goal stands at $149.0, suggesting a possible 12.83% upside.
Evaluating Scores Amongst Business Friends
On this evaluation, we delve into the analyst rankings and common 1-year value targets of IQVIA Hldgs, Waters and Illumina, three key business gamers, providing insights into their relative efficiency expectations and market positioning.
- The prevailing sentiment amongst analysts is an Outperform trajectory for IQVIA Hldgs, with a median 1-year value goal of $261.21, implying a possible 97.8% upside.
- The prevailing sentiment amongst analysts is an Impartial trajectory for Waters, with a median 1-year value goal of $370.0, implying a possible 180.18% upside.
- For Illumina, analysts challenge an Impartial trajectory, with a median 1-year value goal of $173.56, indicating a possible 31.43% upside.
Abstract of Friends Evaluation
The peer evaluation abstract supplies a snapshot of key metrics for IQVIA Hldgs, Waters and Illumina, illuminating their respective standings inside the business. These metrics provide priceless insights into their market positions and comparative efficiency.
Firm | Consensus | Income Progress | Gross Revenue | Return on Fairness |
---|---|---|---|---|
Agilent Applied sciences | Impartial | -5.62% | $855M | 4.65% |
IQVIA Hldgs | Outperform | 4.28% | $1.38B | 4.17% |
Waters | Impartial | 4.02% | $438.65M | 10.71% |
Illumina | Impartial | -3.49% | $745M | 39.60% |
Key Takeaway:
Agilent Applied sciences ranks within the center amongst friends for Consensus score. It’s on the backside for Income Progress. For Gross Revenue, it’s on the prime. By way of Return on Fairness, Agilent Applied sciences is on the backside in comparison with its friends.
Delving into Agilent Applied sciences’s Background
Initially spun out of Hewlett-Packard in 1999, Agilent has developed into a number one life science and diagnostic agency. In the present day, Agilent’s measurement applied sciences serve a broad base of consumers with its three working segments: life science and utilized instruments, cross lab consisting of consumables and companies associated to life science and utilized instruments, and diagnostics and genomics. Over half of its gross sales are generated from the biopharmaceutical, chemical, and superior supplies finish markets, which we view because the stickiest finish markets, but it surely additionally helps scientific lab, environmental, forensics, meals, tutorial, and government-related organizations. The corporate is geographically various, with operations within the US and China representing the most important nation concentrations.
Agilent Applied sciences: A Monetary Overview
Market Capitalization: Positioned above business common, the corporate’s market capitalization underscores its superiority in dimension, indicative of a robust market presence.
Income Progress: Agilent Applied sciences’s income development over a interval of three months has confronted challenges. As of 31 July, 2024, the corporate skilled a income decline of roughly -5.62%. This means a lower within the firm’s top-line earnings. As in comparison with rivals, the corporate encountered difficulties, with a development charge decrease than the common amongst friends within the Well being Care sector.
Internet Margin: Agilent Applied sciences’s web margin excels past business benchmarks, reaching 17.87%. This signifies environment friendly value administration and powerful monetary well being.
Return on Fairness (ROE): Agilent Applied sciences’s ROE stands out, surpassing business averages. With a powerful ROE of 4.65%, the corporate demonstrates efficient use of fairness capital and powerful monetary efficiency.
Return on Property (ROA): Agilent Applied sciences’s monetary energy is mirrored in its distinctive ROA, which exceeds business averages. With a outstanding ROA of 2.58%, the corporate showcases environment friendly use of belongings and powerful monetary well being.
Debt Administration: With a below-average debt-to-equity ratio of 0.5, Agilent Applied sciences adopts a prudent monetary technique, indicating a balanced strategy to debt administration.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.